Use Cases mapped along the prostate cancer management continuum

Use Cases mapped along the prostate cancer management continuum

Nowadays, prostate cancer is highly curable if detected in its early stages. Indeed, when organ-confined at diagnosis, the five-year survival rate of prostate cancer is close to 100%. Unfortunately, current prostate cancer diagnostic pipeline has several limitations. Prostate specific antigen (PSA) has a low sensitivity and specificity.

read more
D6.1 Vendor Specific AI Models

D6.1 Vendor Specific AI Models

Deliverable 6.1, led by partner RADBOUDUMC, titled ”Development of Vendor-Specific AI Models,” describes the work performed in Tasks 6.1, 6.2, and 6.3 in WP6. Task 6.1 describes the ”Prospective dataupload to the platform” (Leader: RADBOUDUMC, Participants: FPO,...

read more
D3.6 Final Data Management Plan

D3.6 Final Data Management Plan

This deliverable based on the DoW entitled “Final Data Management Plan (DMP)” is an updatedversion of the Pro-CAncer-I project’s DMP (D3.5), in accordance with the regulations of the Pilotaction on Open Access to Research Data of the Horizon 2020 program (H2020). It...

read more
D5.1 Retrospective Data Retrieval and upload

D5.1 Retrospective Data Retrieval and upload

This deliverable describes the process performed to retrieve Retrospective Data and upload themto the ProCAncer-I platform, as it is defined in the relevant task 5.1 of the DoA. In more detail,the task 5.1 states that Retrospective examinations that fulfill inclusion...

read more
D5.2 Pre-processing tools

D5.2 Pre-processing tools

ProCAncer-I aims to develop novel AI models in order to add precision in the management ofprostate cancer patients by providing diagnostic tools able to reduce overdiagnosis andovertreatment. To this end, a unique dataset from the project's clinical sites is being...

read more
D3.7 Open Research Data Pilot

D3.7 Open Research Data Pilot

D3.7 “Open Research Data Pilot” of the project ProCAncer-I is prepared under the activities of WP3 - Dissemination, Communication, Open data availability and Data management Plan. In line with the principles of Open Access to Research Data, ProCAncer-I will provide...

read more

Highlights

6th Consortium Meeting in Lisbon

6th Consortium Meeting in Lisbon

The 6th ProCAncer-I Consortium Meeting took place on the 28 & 29 of June 2023, at Champalimaud Foundation, in Lisbon. The meeting was hybrid and more than 55 people attended the meeting. During the consortium meeting, we discussed the progress and various issues...

Stay in touch!